tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Beam Therapeutics provides updata on BEAM-302 development progress
PremiumThe FlyBeam Therapeutics provides updata on BEAM-302 development progress
3d ago
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
Premium
Market News
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
11d ago
Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off
Premium
Market News
Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off
1M ago
Cathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics today
1M ago
Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
Premium
Ratings
Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
1M ago
3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
1M ago
Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease, Justifying Buy Rating
PremiumRatingsBeam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease, Justifying Buy Rating
2M ago
Beam Therapeutics’ BEAM-101: Promising Advancements in Sickle Cell Disease Treatment with Strong Phase 1/2 Trial Results
Premium
Ratings
Beam Therapeutics’ BEAM-101: Promising Advancements in Sickle Cell Disease Treatment with Strong Phase 1/2 Trial Results
2M ago
Beam Therapeutics announces new data from BEACON Phase 1/2 trial
Premium
The Fly
Beam Therapeutics announces new data from BEACON Phase 1/2 trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100